307 related articles for article (PubMed ID: 19215788)
21. WT1 monitoring in core binding factor AML: comparison with specific chimeric products.
Lasa A; Carricondo M; Estivill C; Bussaglia E; Gich I; Brunet S; Aventin A; Sierra J; Nomdedéu JF
Leuk Res; 2009 Dec; 33(12):1643-9. PubMed ID: 19427034
[TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion of cbfb resulting in cbfb-Myh11 fusion.
Douet-Guilbert N; Chauveau A; Gueganic N; Guillerm G; Tous C; Le Bris MJ; Basinko A; Morel F; Ugo V; De Braekeleer M
Hematol Oncol; 2017 Sep; 35(3):385-389. PubMed ID: 28906004
[TBL] [Abstract][Full Text] [Related]
23. [Detection of CBF beta-MYH11 fusion transcript and inv(16)(p13;q22) in acute myelomonocytic leukemia(M4) by RT-PCR and FISH].
He K; Gu B; Cao Q
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):23-6. PubMed ID: 10921098
[TBL] [Abstract][Full Text] [Related]
24. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification.
Hébert J; Cayuela JM; Daniel MT; Berger R; Sigaux F
Blood; 1994 Oct; 84(7):2291-6. PubMed ID: 7919348
[TBL] [Abstract][Full Text] [Related]
25. A case of acute myeloid leukemia with inv(16)(p13q22) reveals a novel MYH11 breakpoint and a new CBF beta-MYH11 transcript variant.
Rowe D; Strain L; Lowe C; Jones G
Haematologica; 2007 Oct; 92(10):1433-4. PubMed ID: 18024381
[TBL] [Abstract][Full Text] [Related]
26. Banding and molecular cytogenetic studies detected a CBFB-MYH11 fusion gene that appeared as abnormal chromosomes 1 and 16 in a baby with acute myeloid leukemia FAB M4-Eo.
Macedo Silva ML; Raimondi SC; Abdelhay E; Gross M; Mkrtchyan H; de Figueiredo AF; Ribeiro RC; de Jesus Marques-Salles T; Sobral ES; Gerardin Land MP; Liehr T
Cancer Genet Cytogenet; 2008 Apr; 182(1):56-60. PubMed ID: 18328953
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
[TBL] [Abstract][Full Text] [Related]
28. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature.
Fujieda A; Nishii K; Tamaru T; Otsuki S; Kobayashi K; Monma F; Ohishi K; Nakase K; Katayama N; Shiku H
Leuk Res; 2006 Aug; 30(8):1053-7. PubMed ID: 16504290
[TBL] [Abstract][Full Text] [Related]
29. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
[TBL] [Abstract][Full Text] [Related]
30. Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo.
Hernández JM; González MB; Granada I; Gutiérrez N; Chillón C; Ramos F; Ribera JM; González M; Feliu E; San Miguel J
Haematologica; 2000 May; 85(5):481-5. PubMed ID: 10800163
[TBL] [Abstract][Full Text] [Related]
31. The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis.
Duan W; Liu X; Jia J; Wang J; Gong L; Jiang Q; Zhao T; Wang Y; Zhang X; Xu L; Zhao X; Qin Y; Shi H; Chang Y; Huang X; Jiang H
Br J Haematol; 2021 Jan; 192(2):265-271. PubMed ID: 32588434
[TBL] [Abstract][Full Text] [Related]
32. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.
Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP
Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376
[TBL] [Abstract][Full Text] [Related]
33. High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study.
Mitterbauer M; Laczika K; Novak M; Mitterbauer G; Hilgarth B; Pirc-Danoewinata H; Schwarzinger I; Haas OA; Fonatsch C; Lechner K; Jaeger U
Am J Clin Pathol; 2000 Mar; 113(3):406-10. PubMed ID: 10705822
[TBL] [Abstract][Full Text] [Related]
34. Spectral karyotyping and fluorescence in situ hybridization analyses identified a novel three-way translocation involving inversion 16 in therapy-related acute myeloid leukemia M4eo.
Ohsaka A; Otsubo K; Yokota H; Hisa T; Saito H; Kozaki T
Cancer Genet Cytogenet; 2008 Jul; 184(2):113-8. PubMed ID: 18617061
[TBL] [Abstract][Full Text] [Related]
35. The gene product of CBFB-MYH11.
Claxton D; Xie QS; Patel S; Deisseroth AB; Kornblau S
Leukemia; 1996 Sep; 10(9):1479-85. PubMed ID: 8751466
[TBL] [Abstract][Full Text] [Related]
36. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts.
van der Reijden BA; Lombardo M; Dauwerse HG; Giles RH; Mühlematter D; Bellomo MJ; Wessels HW; Beverstock GC; van Ommen GJ; Hagemeijer A
Blood; 1995 Jul; 86(1):277-82. PubMed ID: 7795233
[TBL] [Abstract][Full Text] [Related]
37. Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered.
van der Reijden BA; Dauwerse HG; Giles RH; Jagmohan-Changur S; Wijmenga C; Liu PP; Smit B; Wessels HW; Beverstock GC; Jotterand-Bellomo M; Martinet D; Mühlematter D; Lafage-Pochitaloff M; Gabert J; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
Oncogene; 1999 Jan; 18(2):543-50. PubMed ID: 9927211
[TBL] [Abstract][Full Text] [Related]
38. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP
Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155
[TBL] [Abstract][Full Text] [Related]
39. Acute promyelocytic leukemia with insertion of PML exon 7a and partial deletion of exon 3 of RARA: a novel variant transcript related to aggressive course and not detected with real-time polymerase chain reaction analysis.
Park TS; Kim JS; Song J; Lee KA; Yoon S; Suh B; Lee JH; Lee HJ; Kim JK; Choi JR
Cancer Genet Cytogenet; 2009 Jan; 188(2):103-7. PubMed ID: 19100514
[TBL] [Abstract][Full Text] [Related]
40. Childhood acute myeloid leukemia with CBFbeta-MYH11 rearrangement: study of incidence, morphology, cytogenetics, and clinical outcomes of Chinese in Hong Kong.
Chan NP; Wong WS; Ng MH; Tsang KS; Lau TT; Leung Y; Chik KW; Shing MM; Li CK
Am J Hematol; 2004 Jul; 76(3):300-3. PubMed ID: 15224374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
